Weight Loss Following Liraglutide Therapy in a Patient With Smith-Magenis Syndrome: A Case Report
Dave K Garg, Jeffrey Wei · 2026
Read Weight Loss Following Liraglutide Therapy in a Patient With Smith-Magenis Syndrome: A Case Report by Dave K Garg, Jeffrey Wei (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13391223.txt.
Description
Dave K Garg and Jeffrey Wei report, in 2026, substantial weight loss with a daily diabetes injection in a young man with a rare genetic obesity syndrome. Smith-Magenis syndrome drove excessive hunger and rapid weight gain despite portion control and behaviour support over five years.
With prediabetes, abnormal lipids, and fatty liver emerging, the team started liraglutide, a GLP-1 receptor agonist, and raised it gradually to the maximum dose over five months. The patient tolerated it without severe stomach side effects and, with lifestyle support, lost a large amount of weight over eleven months. Endocrine readers gain a single-case signal that appetite-targeting drugs can work even when obesity has a strong genetic driver.
Catalog record
| CREATOR | Dave K Garg, Jeffrey Wei |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 17086 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |